262 related articles for article (PubMed ID: 26260812)
1. The utility of molecular markers in pre-operative assessment of thyroid nodules.
Bhatia P; Abd Elmageed ZY; Friedlander P; Aslam R; Kandil E
Future Oncol; 2015; 11(16):2343-50. PubMed ID: 26260812
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of ancillary molecular testing in differentiation of benign and malignant thyroid nodules.
Bhatia P; Deniwar A; Friedlander P; Aslam R; Kandil E
Anticancer Res; 2015 Mar; 35(3):1237-41. PubMed ID: 25750270
[TBL] [Abstract][Full Text] [Related]
3. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
4. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
[TBL] [Abstract][Full Text] [Related]
5. Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
De Napoli L; Bakkar S; Ambrosini CE; Materazzi G; Proietti A; Macerola E; Basolo F; Miccoli P
Thyroid; 2016 Mar; 26(3):390-4. PubMed ID: 26548748
[TBL] [Abstract][Full Text] [Related]
6. BRAF V600 co-testing is technically feasible in conventional thyroid fine needle aspiration (FNA) cytology smears and can reduce the need for completion thyroidectomy.
Poller DN; Glaysher S
Cytopathology; 2014 Jun; 25(3):155-9. PubMed ID: 24164374
[TBL] [Abstract][Full Text] [Related]
7. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
[TBL] [Abstract][Full Text] [Related]
8. False negative cytology in large thyroid nodules.
Giles WH; Maclellan RA; Gawande AA; Ruan DT; Alexander EK; Moore FD; Cho NL
Ann Surg Oncol; 2015 Jan; 22(1):152-7. PubMed ID: 25074665
[TBL] [Abstract][Full Text] [Related]
9. Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides.
Benjamin H; Schnitzer-Perlman T; Shtabsky A; VandenBussche CJ; Ali SZ; Kolar Z; Pagni F; ; Bar D; Meiri E
Cancer Cytopathol; 2016 Oct; 124(10):711-721. PubMed ID: 27223344
[TBL] [Abstract][Full Text] [Related]
10. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
[TBL] [Abstract][Full Text] [Related]
11. Fine needle aspiration biopsy-RT-PCR molecular analysis of thyroid nodules: a useful preoperative diagnostic tool.
Letsas KP; Andrikoula M; Tsatsoulis A
Minerva Endocrinol; 2006 Jun; 31(2):179-82. PubMed ID: 16682941
[TBL] [Abstract][Full Text] [Related]
12. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
Freitas BC; Cerutti JM
Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
[TBL] [Abstract][Full Text] [Related]
13. Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery.
Mehta V; Nikiforov YE; Ferris RL
Head Neck; 2013 Oct; 35(10):1499-506. PubMed ID: 22972563
[TBL] [Abstract][Full Text] [Related]
14. New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers.
Nikiforov YE; Yip L; Nikiforova MN
Clin Cancer Res; 2013 May; 19(9):2283-8. PubMed ID: 23422095
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of fine needle aspiration in the pre-operative diagnosis of thyroid neoplasia.
Vojvodich SM; Ballagh RH; Cramer H; Lampe HB
J Otolaryngol; 1994 Oct; 23(5):360-5. PubMed ID: 7807641
[TBL] [Abstract][Full Text] [Related]
16. Three-gene molecular diagnostic model for thyroid cancer.
Prasad NB; Kowalski J; Tsai HL; Talbot K; Somervell H; Kouniavsky G; Wang Y; Dackiw AP; Westra WH; Clark DP; Libutti SK; Umbricht CB; Zeiger MA
Thyroid; 2012 Mar; 22(3):275-84. PubMed ID: 22280184
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules.
Bohacek L; Milas M; Mitchell J; Siperstein A; Berber E
Ann Surg Oncol; 2012 Jan; 19(1):45-51. PubMed ID: 21633868
[TBL] [Abstract][Full Text] [Related]
18. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
[TBL] [Abstract][Full Text] [Related]
19. Thyroid nodules: does the suspicion for malignancy really justify the increased thyroidectomy rates?
Sakorafas GH; Peros G; Farley DR
Surg Oncol; 2006 Jul; 15(1):43-55. PubMed ID: 16950080
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
